Comparison of metrizamide with other myelographic agents

Comparison of metrizamide with other myelographic agents

Metrizamide is an attractive myelographic agent with several advantages over other available myelographic agents. Radiographic detail is generally superior to Pantopaque and gas myelography, the material need not be aspiradted and does not appear to result in long-term complicaitons. Because of its...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical orthopaedics and related research 1977 (127), p.111-119
1. Verfasser: Bentson, J R
Format: Artikel
Sprache:eng
Schlagworte:
Contrast Media
Gases
Headache - chemically induced
Humans
Iophendylate - adverse effects
Metrizamide - adverse effects
Myelography
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119
container_issue 127
container_start_page 111
container_title Clinical orthopaedics and related research
container_volume
creator Bentson, J R
description Metrizamide is an attractive myelographic agent with several advantages over other available myelographic agents. Radiographic detail is generally superior to Pantopaque and gas myelography, the material need not be aspiradted and does not appear to result in long-term complicaitons. Because of its low neuro-toxicity, it may be allowed to come into contact with the spinal cord and brain, unlike other water-soluble agents. Its main disadvantages are its tendency to diffuse into the CSF when run from one portion of the spinal canal to another and the occurrence of acute toxic effects such as vomiting and, rarely, seizures.
doi_str_mv 10.1097/00003086-197709000-00013
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00003086_197709000_00013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>912965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c169t-1467497b2a730e47fa1483a08e8f8deff2363414f281dea9109648645817a23f3</originalsourceid><addsrcrecordid>eNo9j9tKAzEQhnPhqVbfwIu8wGomyeZwKUWtUPBGwbuQ7ibdSLdZkhWpT2_qageGnx_mG_gQwkBugWh5R8owokQFWkqiS6vKAjtBs5K60hTeL9Blzh-HQ17Tc3SmgWpRz5BaxH6wKeS4w9Hj3o0pfNs-tA5_hbHDcexcwv3ebeMm2aELDbYbtxvzFTr1dpvd9V_O0dvjw-tiWa1enp4X96uqAaHHCriQXMs1tZIRx6W3wBWzRDnlVeu8p0wwDtxTBa2zuggJrgSvFUhLmWdzpKa_TYo5J-fNkEJv094AMQd9869vjvrmV7-gNxM6fK571x7ByZ39AGdzVqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of metrizamide with other myelographic agents</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Bentson, J R</creator><creatorcontrib>Bentson, J R</creatorcontrib><description>Metrizamide is an attractive myelographic agent with several advantages over other available myelographic agents. Radiographic detail is generally superior to Pantopaque and gas myelography, the material need not be aspiradted and does not appear to result in long-term complicaitons. Because of its low neuro-toxicity, it may be allowed to come into contact with the spinal cord and brain, unlike other water-soluble agents. Its main disadvantages are its tendency to diffuse into the CSF when run from one portion of the spinal canal to another and the occurrence of acute toxic effects such as vomiting and, rarely, seizures.</description><identifier>ISSN: 0009-921X</identifier><identifier>DOI: 10.1097/00003086-197709000-00013</identifier><identifier>PMID: 912965</identifier><language>eng</language><publisher>United States</publisher><subject>Contrast Media ; Gases ; Headache - chemically induced ; Humans ; Iophendylate - adverse effects ; Metrizamide - adverse effects ; Myelography</subject><ispartof>Clinical orthopaedics and related research, 1977 (127), p.111-119</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/912965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bentson, J R</creatorcontrib><title>Comparison of metrizamide with other myelographic agents</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><description>Metrizamide is an attractive myelographic agent with several advantages over other available myelographic agents. Radiographic detail is generally superior to Pantopaque and gas myelography, the material need not be aspiradted and does not appear to result in long-term complicaitons. Because of its low neuro-toxicity, it may be allowed to come into contact with the spinal cord and brain, unlike other water-soluble agents. Its main disadvantages are its tendency to diffuse into the CSF when run from one portion of the spinal canal to another and the occurrence of acute toxic effects such as vomiting and, rarely, seizures.</description><subject>Contrast Media</subject><subject>Gases</subject><subject>Headache - chemically induced</subject><subject>Humans</subject><subject>Iophendylate - adverse effects</subject><subject>Metrizamide - adverse effects</subject><subject>Myelography</subject><issn>0009-921X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1977</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j9tKAzEQhnPhqVbfwIu8wGomyeZwKUWtUPBGwbuQ7ibdSLdZkhWpT2_qageGnx_mG_gQwkBugWh5R8owokQFWkqiS6vKAjtBs5K60hTeL9Blzh-HQ17Tc3SmgWpRz5BaxH6wKeS4w9Hj3o0pfNs-tA5_hbHDcexcwv3ebeMm2aELDbYbtxvzFTr1dpvd9V_O0dvjw-tiWa1enp4X96uqAaHHCriQXMs1tZIRx6W3wBWzRDnlVeu8p0wwDtxTBa2zuggJrgSvFUhLmWdzpKa_TYo5J-fNkEJv094AMQd9869vjvrmV7-gNxM6fK571x7ByZ39AGdzVqQ</recordid><startdate>1977</startdate><enddate>1977</enddate><creator>Bentson, J R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1977</creationdate><title>Comparison of metrizamide with other myelographic agents</title><author>Bentson, J R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c169t-1467497b2a730e47fa1483a08e8f8deff2363414f281dea9109648645817a23f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1977</creationdate><topic>Contrast Media</topic><topic>Gases</topic><topic>Headache - chemically induced</topic><topic>Humans</topic><topic>Iophendylate - adverse effects</topic><topic>Metrizamide - adverse effects</topic><topic>Myelography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bentson, J R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bentson, J R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of metrizamide with other myelographic agents</atitle><jtitle>Clinical orthopaedics and related research</jtitle><addtitle>Clin Orthop Relat Res</addtitle><date>1977</date><risdate>1977</risdate><issue>127</issue><spage>111</spage><epage>119</epage><pages>111-119</pages><issn>0009-921X</issn><abstract>Metrizamide is an attractive myelographic agent with several advantages over other available myelographic agents. Radiographic detail is generally superior to Pantopaque and gas myelography, the material need not be aspiradted and does not appear to result in long-term complicaitons. Because of its low neuro-toxicity, it may be allowed to come into contact with the spinal cord and brain, unlike other water-soluble agents. Its main disadvantages are its tendency to diffuse into the CSF when run from one portion of the spinal canal to another and the occurrence of acute toxic effects such as vomiting and, rarely, seizures.</abstract><cop>United States</cop><pmid>912965</pmid><doi>10.1097/00003086-197709000-00013</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-921X
ispartof Clinical orthopaedics and related research, 1977 (127), p.111-119
issn 0009-921X
language eng
recordid cdi_crossref_primary_10_1097_00003086_197709000_00013
source MEDLINE; Journals@Ovid Complete
subjects Contrast Media
Gases
Headache - chemically induced
Humans
Iophendylate - adverse effects
Metrizamide - adverse effects
Myelography
title Comparison of metrizamide with other myelographic agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T08%3A59%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20metrizamide%20with%20other%20myelographic%20agents&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=Bentson,%20J%20R&rft.date=1977&rft.issue=127&rft.spage=111&rft.epage=119&rft.pages=111-119&rft.issn=0009-921X&rft_id=info:doi/10.1097/00003086-197709000-00013&rft_dat=%3Cpubmed_cross%3E912965%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/912965&rfr_iscdi=true